EssilorLuxottica Strong revenue growth in the first quarter Group’s revenue up 8.1% at current and 7.3% at constant exchange rates1 in Q1 Sound growth in both PS and DTC channels, with comparable-store sales3 up 8% EMEA growing 10% at constant exchange rates1, equally boosted by the two channels NA growing 4%, with solid trends in DTC and resilient demand in PS Asia-Pacific up double digits, with myopia solutions strong in China Ray-Ban Meta growing fast, with high penetration of Transitions After the US and Italy, Nuance Audio launched in France and starting in the UK and Germany Implementing measures to manage the impact of the US import duties Paris, France (April 23, 2025 - 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the first quarter of 2025 reached Euro 6,848 million, representing a year-on-year increase of 7.3% at constant exchange rates1 compared to the first quarter of 2024 (+8.1% at current exchange rates). Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica commented: “In the first quarter, we successfully maintained strong momentum, with all regions and businesses contributing to steady growth (in constant currency terms) – each playing an integral role in advancing our journey in the wearables and med-tech space. From the new six-year clinical data confirming long-term efficacy of Stellest in slowing myopia progression to the transformative Nuance Audio launch marking an entirely new category in the U.S., Italy and France, we are making significant strides toward our strategic goals. Our brands are showing the power of relevance like never before, including Ray-Ban Meta’s extraordinary trajectory, Oakley celebrating its 50th year of being the world’s favorite sport performance brand and Oliver Peoples extending its partnership with legend Roger Federer. At the heart of this momentum are our 200,000 dedicated colleagues, whose commitment and passion fuel our continued success. Their growing involvement as shareholders stands a powerful testament to their trust in our Company and the values that define us. In a time of uncertainty, we advance with purpose, ambition and confidence in the future we are building together”. Attachment DOWNLOAD THE PRESS RELEASE View Comments
EssilorLuxottica: Q1 2025 Revenue - Strong revenue growth in the first quarter
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...